Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults

Saved in:
Bibliographic Details
Published in:Endocrine Regulations
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553114831814657
collection WordPress RSS
FRELIP Feed Integration
container_title Endocrine Regulations
description
discipline_display Endocrinology
discipline_facet Endocrinology
format Online Article
RSS Article
genre Journal Article
id rss_article:73744
institution FRELIP
journal_source_facet Endocrine Regulations
last_indexed 2026-06-20T21:31:51.751Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
Endocrinology
General
Endocrinology
sub_discipline_display General
sub_discipline_facet General
subject_display Endocrinology
General
Endocrinology
subject_facet Endocrinology
General
Endocrinology
title Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_alt Mirtazapina para los efectos secundarios gastrointestinales de la terapia con agonistas del receptor del péptido similar al glucagón tipo 1 en adultos mayores
Mirtazapine pour les effets secondaires gastro-intestinaux du traitement par agonistes du récepteur du glucagon-like peptide-1 chez les personnes âgées
Mirtazapina para efeitos colaterais gastrointestinais da terapia com agonistas do receptor de peptídeo semelhante ao glucagon-1 em idosos
title_auth Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_es_txt Mirtazapina para los efectos secundarios gastrointestinales de la terapia con agonistas del receptor del péptido similar al glucagón tipo 1 en adultos mayores
title_fr_txt Mirtazapine pour les effets secondaires gastro-intestinaux du traitement par agonistes du récepteur du glucagon-like peptide-1 chez les personnes âgées
title_full Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_fullStr Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_full_unstemmed Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_pt_txt Mirtazapina para efeitos colaterais gastrointestinais da terapia com agonistas do receptor de peptídeo semelhante ao glucagon-1 em idosos
title_short Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
title_sort mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
topic Endocrinology
General
Endocrinology
url https://sciendo.com/article/10.2478/enr-2025-0030